Literature DB >> 21057907

Microcalorimetric method to assess phagocytosis: macrophage-nanoparticle interactions.

M H D Kamal Al-Hallak1, Muhammad Khan Sarfraz, Shirzad Azarmi, M H Gilzad Kohan, Wilson H Roa, Raimar Löbenberg.   

Abstract

This study evaluated the use of isothermal microcalorimetry (ITMC) to detect macrophage-nanoparticle interactions. Four different nanoparticle (NP) formulations were prepared: uncoated poly(isobutyl cyanoacrylate) (PIBCA), polysorbate-80-coated PIBCA, gelatin, and mannosylated gelatin NPs. Changes in NP formulations were aimed to either enhance or decrease macrophage-NP interactions via phagocytosis. Alveolar macrophages were cultured on glass slabs and inserted in the ITMC instrument. Thermal activities of the macrophages alone and after titration of 100 μL of NP suspensions were compared. The relative interactive coefficients of macrophage-NP interactions were calculated using the heat exchange observed after NP titration. Control experiments were performed using cytochalasin B (Cyto B), a known phagocytosis inhibitor. The results of NP titration showed that the total thermal activity produced by macrophages changed according to the NP formulation. Mannosylated gelatin NPs were associated with the highest heat exchange, 75.4 ± 7.5 J, and thus the highest relative interactive coefficient, 9,269 ± 630 M-1. Polysorbate-80-coated NPs were associated with the lowest heat exchange, 15.2 ± 3.4 J, and the lowest interactive coefficient, 890 ± 120 M-1. Cyto B inhibited macrophage response to NPs, indicating a connection between the thermal activity recorded and NP phagocytosis. These results are in agreement with flow cytometry results. ITMC is a valuable tool to monitor the biological responses to nano-sized dosage forms such as NPs. Since the thermal activity of macrophage-NP interactions differed according to the type of NPs used, ITMC may provide a method to better understand phagocytosis and further the development of colloidal dosage forms.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21057907      PMCID: PMC3032094          DOI: 10.1208/s12248-010-9240-y

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  32 in total

Review 1.  Long-circulating and target-specific nanoparticles: theory to practice.

Authors:  S M Moghimi; A C Hunter; J C Murray
Journal:  Pharmacol Rev       Date:  2001-06       Impact factor: 25.468

2.  Secondary cytotoxicity mediated by alveolar macrophages: a contribution to the total efficacy of nanoparticles in lung cancer therapy?

Authors:  Kamal M H D Al-Hallak; Shirzad Azarmi; Anwar Anwar-Mohamed; Wilson H Roa; Raimar Löbenberg
Journal:  Eur J Pharm Biopharm       Date:  2010-05-07       Impact factor: 5.571

3.  Fluorescence and electron microscopy probes for cellular and tissue uptake of poly(D,L-lactide-co-glycolide) nanoparticles.

Authors:  Jayanth Panyam; Sanjeeb K Sahoo; Swayam Prabha; Tom Bargar; Vinod Labhasetwar
Journal:  Int J Pharm       Date:  2003-08-27       Impact factor: 5.875

Review 4.  Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties.

Authors:  S M Moghimi; J Szebeni
Journal:  Prog Lipid Res       Date:  2003-11       Impact factor: 16.195

5.  Pulmonary toxicity of polysorbate-80-coated inhalable nanoparticles; in vitro and in vivo evaluation.

Authors:  M H D Kamal Al-Hallak; Shirzad Azarmi; Chris Sun; Patrick Lai; Elmar J Prenner; Wilson H Roa; Raimar Löbenberg
Journal:  AAPS J       Date:  2010-04-20       Impact factor: 4.009

Review 6.  Targeted delivery of nanoparticles for the treatment of lung diseases.

Authors:  Shirzad Azarmi; Wilson H Roa; Raimar Löbenberg
Journal:  Adv Drug Deliv Rev       Date:  2008-02-06       Impact factor: 15.470

7.  Mannosylated gelatin nanoparticles bearing an anti-HIV drug didanosine for site-specific delivery.

Authors:  Sanjay K Jain; Yashwant Gupta; Anekant Jain; Asheesh R Saxena; Piush Khare; Aviral Jain
Journal:  Nanomedicine       Date:  2008-01-22       Impact factor: 5.307

8.  Significant transport of doxorubicin into the brain with polysorbate 80-coated nanoparticles.

Authors:  A E Gulyaev; S E Gelperina; I N Skidan; A S Antropov; G Y Kivman; J Kreuter
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

9.  Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro.

Authors:  C E Soma; C Dubernet; G Barratt; S Benita; P Couvreur
Journal:  J Control Release       Date:  2000-08-10       Impact factor: 9.776

10.  Physical characterization and macrophage cell uptake of mannan-coated nanoparticles.

Authors:  Zhengrong Cui; Cheng-Hsuan Hsu; Russell J Mumper
Journal:  Drug Dev Ind Pharm       Date:  2003-07       Impact factor: 3.225

View more
  1 in total

Review 1.  Technologies for investigating the physiological barriers to efficient lipid nanoparticle-siRNA delivery.

Authors:  Bin Shi; Marc Abrams
Journal:  J Histochem Cytochem       Date:  2013-03-14       Impact factor: 2.479

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.